These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6540782)

  • 21. In vitro cell growth inhibition by metallocene dichlorides.
    Köpf-Maier P; Wagner W; Köpf H
    Cancer Chemother Pharmacol; 1981; 5(4):237-41. PubMed ID: 7261252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Organ distribution and pharmacokinetics of titanium after treatment with titanocene dichloride.
    Köpf-Maier P; Brauchle U; Henssler A
    Toxicology; 1988 Oct; 51(2-3):291-8. PubMed ID: 3176032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor inhibition by titanocene complexes: influence on xenografted human adenocarcinomas of the gastrointestinal tract.
    Köpf-Maier P
    Cancer Chemother Pharmacol; 1989; 23(4):225-30. PubMed ID: 2924380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor organometallics. I. Activity of some diphenyltin(IV) and diphenylantimony(III) derivatives on in vitro and in vivo Ehrlich ascites tumor.
    Bara A; Socaciu C; Silvestru C; Haiduc I
    Anticancer Res; 1991; 11(4):1651-5. PubMed ID: 1836124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor activity of Titanocene Y against freshly explanted human breast tumor cells and in xenografted MCF-7 tumors in mice.
    Beckhove P; Oberschmidt O; Hanauske AR; Pampillón C; Schirrmacher V; Sweeney NJ; Strohfeldt K; Tacke M
    Anticancer Drugs; 2007 Mar; 18(3):311-5. PubMed ID: 17264764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-proliferative activity and mechanism of action of titanocene dichloride.
    Christodoulou CV; Eliopoulos AG; Young LS; Hodgkins L; Ferry DR; Kerr DJ
    Br J Cancer; 1998 Jun; 77(12):2088-97. PubMed ID: 9649119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The first organoantimony(III) compounds possessing antitumor properties: diphenylantimony(III) derivatives of dithiophosphorus ligands.
    Silvestru C; Socaciu C; Bara A; Haiduc I
    Anticancer Res; 1990; 10(3):803-4. PubMed ID: 2369094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antitumor mechanisms of carboxyethyl-germanium sesquioxide (Ge-132) in mice bearing Ehrlich ascites tumors].
    Suzuki F
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):127-34. PubMed ID: 3800401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato)titanium (IV) compounds. A new class of antineoplastic agents.
    Keller HJ; Keppler B; Schmähl D
    J Cancer Res Clin Oncol; 1983; 105(1):109-10. PubMed ID: 6682104
    [No Abstract]   [Full Text] [Related]  

  • 30. Antitumor activity of titanocene amino acid complexes.
    Köpf-Maier P; Tornieporth-Oetting IC
    Biometals; 1996 Jul; 9(3):267-71. PubMed ID: 8696077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical evaluation of diethoxy-(1-phenyl-1,3-butanedionato) titanium (IV) in human tumour xenografts.
    Mattern J; Keppler B; Volm M
    Arzneimittelforschung; 1984; 34(10):1289-90. PubMed ID: 6549134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of vinorelbine and titanocene dichloride on human tumour xenografts in nude mice.
    Friedrich M; Villena-Heinsen C; Farnhammer C; Schmidt W
    Eur J Gynaecol Oncol; 1998; 19(4):333-7. PubMed ID: 9744720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro anti-tumor activity studies of bridged and unbridged benzyl-substituted titanocenes.
    Kelter G; Sweeney NJ; Strohfeldt K; Fiebig HH; Tacke M
    Anticancer Drugs; 2005 Nov; 16(10):1091-8. PubMed ID: 16222151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrastructural localization of cisplatin in Ehrlich ascites tumor cells.
    Rodilla V; Pertusa J; Pellicer JA
    Cancer Lett; 1988 Mar; 39(2):179-83. PubMed ID: 3359413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of T-cells and macrophages in the antitumor activity of carboxyethylgermanium sesquioxide (Ge-132).
    Suzuki F; Brutkiewicz RR; Pollard RB
    Anticancer Res; 1985; 5(5):479-83. PubMed ID: 3877491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, structure, electrochemistry and spectral characterization of (D-glucopyranose)-4-phenylthiosemicarbazide metal complexes and their antitumor activity against Ehrlich ascites carcinoma in Swiss albino mice.
    Sathisha MP; Budagumpi S; Kulkarni NV; Kurdekar GS; Revankar VK; Pai KS
    Eur J Med Chem; 2010 Jan; 45(1):106-13. PubMed ID: 19854545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiproliferative activity of Titanocene Y against tumor colony-forming units.
    Oberschmidt O; Hanauske AR; Pampillón C; Sweeney NJ; Strohfeldt K; Tacke M
    Anticancer Drugs; 2007 Mar; 18(3):317-21. PubMed ID: 17264765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular distribution of titanium after treatment with the antitumor agent titanocene dichloride: on electron energy loss spectroscopic study.
    Köpf-Maier P; Krahl D
    Naturwissenschaften; 1981 May; 68(5):273-4. PubMed ID: 7242687
    [No Abstract]   [Full Text] [Related]  

  • 39. Antitumor effect of carboplatin combined with hyperthermia on Ehrlich-ascites tumor in vivo.
    Mizuuchi H; Yoshiga K; Sakurai K; Tsumura M; Takada K
    Anticancer Res; 1996; 16(1):381-7. PubMed ID: 8615640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of Cytokines Production by Indomethacin Acute Dose during the Evolution of Ehrlich Ascites Tumor in Mice.
    Gentile LB; Queiroz-Hazarbassanov N; Massoco Cde O; Fecchio D
    Mediators Inflamm; 2015; 2015():924028. PubMed ID: 26347589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.